HK1137142A1 - Drug for treatment of influenza - Google Patents

Drug for treatment of influenza

Info

Publication number
HK1137142A1
HK1137142A1 HK10103858.3A HK10103858A HK1137142A1 HK 1137142 A1 HK1137142 A1 HK 1137142A1 HK 10103858 A HK10103858 A HK 10103858A HK 1137142 A1 HK1137142 A1 HK 1137142A1
Authority
HK
Hong Kong
Prior art keywords
influenza
drug
treatment
prophylactic
therapeutic
Prior art date
Application number
HK10103858.3A
Other languages
English (en)
Inventor
Makoto Yamashita
Yoshihiro Kawaoka
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1137142A1 publication Critical patent/HK1137142A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
HK10103858.3A 2007-03-07 2010-04-21 Drug for treatment of influenza HK1137142A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007056872 2007-03-07
PCT/JP2008/053738 WO2008108323A1 (ja) 2007-03-07 2008-03-03 インフルエンザ治療剤

Publications (1)

Publication Number Publication Date
HK1137142A1 true HK1137142A1 (en) 2010-07-23

Family

ID=39738201

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10103858.3A HK1137142A1 (en) 2007-03-07 2010-04-21 Drug for treatment of influenza

Country Status (17)

Country Link
US (2) US20100204314A1 (de)
EP (1) EP2123271B1 (de)
JP (2) JP5286251B2 (de)
KR (1) KR101473028B1 (de)
CN (1) CN101715343B (de)
AT (1) ATE526960T1 (de)
CA (1) CA2680415A1 (de)
CY (1) CY1112201T1 (de)
DK (1) DK2123271T3 (de)
ES (1) ES2372996T3 (de)
HK (1) HK1137142A1 (de)
HR (1) HRP20110861T1 (de)
PL (1) PL2123271T3 (de)
PT (1) PT2123271E (de)
SI (1) SI2123271T1 (de)
TW (1) TWI424841B (de)
WO (1) WO2008108323A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
AU2011250970B2 (en) * 2010-05-10 2016-12-15 Sinica, Academia Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
JP6038808B2 (ja) * 2011-12-16 2016-12-07 第一三共株式会社 ノイラミン酸誘導体の製造方法
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
EP3041484B1 (de) 2013-09-06 2021-03-03 Academia Sinica Humane inkt-zell-aktivierung mittels glykolipiden mit veränderten glycosylgruppen
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TW201620939A (zh) 2014-01-16 2016-06-16 中央研究院 治療及檢測癌症之組合物及方法
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
EP3149036A4 (de) 2014-05-27 2017-12-27 Academia Sinica Anti-cd20-glycoantikörper und verwendungen davon
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102512592B1 (ko) 2014-05-27 2023-03-21 아카데미아 시니카 항-ｈｅｒ2 글리코항체 및 이의 용도
KR102576850B1 (ko) 2014-05-27 2023-09-11 아카데미아 시니카 박테로이드 기원의 푸코시다제 및 이의 사용 방법
AU2015267044A1 (en) 2014-05-28 2016-12-15 Academia Sinica Anti-TNF-alpha glycoantibodies and uses thereof
CN107001404B (zh) 2014-09-08 2021-06-29 中央研究院 使用醣脂激活人类iNKT细胞
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
AU2015378564A1 (en) 2015-01-24 2017-07-13 Academia Sinica Novel glycan conjugates and methods of use thereof
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｎ−グリカンおよびそのアレイのモジュール合成のための方法
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
DE69709795T2 (de) * 1996-07-22 2002-09-26 Sankyo Co Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung
JP3209946B2 (ja) * 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
US6340702B1 (en) * 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP4151800B2 (ja) 1996-08-13 2008-09-17 第一三共株式会社 ノイラミン酸化合物
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
JP3920041B2 (ja) 2000-04-25 2007-05-30 三共株式会社 ノイラミン酸化合物の水和物及び結晶
DE602006003600D1 (de) 2005-08-22 2008-12-24 Delphi Tech Inc Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad

Also Published As

Publication number Publication date
JP6012076B2 (ja) 2016-10-25
PL2123271T3 (pl) 2012-03-30
SI2123271T1 (sl) 2012-05-31
CN101715343A (zh) 2010-05-26
JPWO2008108323A1 (ja) 2010-06-17
JP5286251B2 (ja) 2013-09-11
PT2123271E (pt) 2011-12-20
US20100204314A1 (en) 2010-08-12
EP2123271B1 (de) 2011-10-05
KR101473028B1 (ko) 2014-12-15
CY1112201T1 (el) 2015-12-09
HRP20110861T1 (hr) 2011-12-31
US20140018418A1 (en) 2014-01-16
EP2123271A4 (de) 2010-03-17
DK2123271T3 (da) 2012-01-23
TW200848018A (en) 2008-12-16
KR20090129414A (ko) 2009-12-16
JP2013139483A (ja) 2013-07-18
CN101715343B (zh) 2012-09-26
TWI424841B (zh) 2014-02-01
EP2123271A1 (de) 2009-11-25
CA2680415A1 (en) 2008-09-12
ES2372996T3 (es) 2012-01-30
WO2008108323A1 (ja) 2008-09-12
ATE526960T1 (de) 2011-10-15

Similar Documents

Publication Publication Date Title
HK1137142A1 (en) Drug for treatment of influenza
HK1139381A1 (en) Bicyclic -amino acid derivative
TW200728307A (en) Novel spirochromanone derivatives
SG171617A1 (en) Therapeutic compounds
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2010004232A (es) Compuesto de indolina de pirimidilo.
WO2007084728A3 (en) 2-imino-benzimidazoles
MX2009012125A (es) Compuestos terapeuticos.
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
HK1159614A1 (en) Caspase inhibitors and uses thereof
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
MX2011011776A (es) Nuevos profarmacos de triptolite.
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
WO2009051223A1 (ja) 白内障処置のための医薬組成物
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
ZA201007603B (en) Therapeutic compounds
MX2011012068A (es) Nucleosidos 2'-fluoro arabino y su utilizaicon.
MX2010001304A (es) Compuestos terapeuticos.
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
TW200606148A (en) Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
BRPI0514020A (pt) oxindóis oxazolidinonas como agentes antibacterianos
WO2007115020A3 (en) Therapeutic prostaglandin compounds for the treatment of glaucoma
UA88766C2 (ru) Производные хинолина для лечения латентного туберкулеза
MX2010004405A (es) Derivados de pirrolo [1,2-c] imidazol para utilizarse en la profilaxis o tratamiento de cancer que es refractario a terapias cancerigenas conocidas.

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: DELETION OF APPLICANT: THE UNIVERSITY OF TOKYO